About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an ...

The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate ...

FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.

Clinicians divided amid growing demand for leucovorin autism drug as major medical groups advise caution over safety and efficacy.

The briefing claimed Tylenol use during pregnancy was linked to autism and promoted leucovorin as a potential autism ...

The FDA declined to endorse leucovorin as a treatment for autism, but approved the drug to treat cerebral folate deficiency, ...

Although FDA Commissioner Marty Makary promised “an exciting treatment” for autism, what the agency delivered was a label ...

Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...

After leucovorin got public attention as a potential autism treatment, families rushed to get it. Many doctors are torn about prescribing an unproven drug but don't want to lose patients' trust.

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...

The FDA has expanded its approval of leucovorin calcium tablets to treat cerebral folate deficiency in patients with a folate receptor 1 gene variant, according to a press release from the agency.

The FDA has approved Wellcovorin (leucovorin) for cerebral folate deficiency (CFD-FOLR1), the first-ever treatment for the rare genetic neurological condition.